Cost-effectiveness of Ivabradine as a Treatment for Systolic Chronic Heart Failure in the United States

被引：0
|
作者：
Kansal, Anuraag R.
Cowie, Martin
Kielhorn, Adrian
Krotneva, Stanimira
Taffazzoli, Ali
Zheng, Ying
Yurgin, Nicole
机构：
来源：
CIRCULATION | 2015年 / 132卷
关键词：
cost effectiveness; systolic chronic heart failure; ivabradine; quality-adjusted life years; hospitalization;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17655
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Cost-Effectiveness of Ivabradine in the Treatment of Chronic Heart Failure
    Adena, Michael A.
    Hamann, Gary
    Sindone, Andrew P.
    HEART LUNG AND CIRCULATION, 2019, 28 (03): : 414 - 422
  • [2] Cost-Effectiveness of Ivabradine for Heart Failure in the United States
    Kansal, Anuraag R.
    Cowie, Martin R.
    Kielhorn, Adrian
    Krotneva, Stanimira
    Tafazzoli, Ali
    Zheng, Ying
    Yurgin, Nicole
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (05):
  • [3] A model to assess the cost-effectiveness of pharmacogenomics tests in chronic heart failure: the case of ivabradine
    Iliza, Ange C.
    Matteau, Alexis
    Guertin, Jason R.
    Mitchell, Dominic
    Fanton-Aita, Fiorella
    Dubois, Anick
    Dube, Marie-Pierre
    Tardif, Jean-Claude
    LeLorier, Jacques
    PHARMACOGENOMICS, 2016, 17 (15) : 1693 - 1706
  • [4] COST-EFFECTIVENESS ANALYSIS OF IVABRADINE IN TREATMENT OF PATIENTS WITH HEART FAILURE IN IRAN
    Taheri, Saeed
    Heidari, Elham
    Aivazi, Mohammad Ali
    Shams-Beyranvand, Mehran
    Varmaghani, Mehdi
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2018, 34 (06) : 576 - 583
  • [5] Cost-Effectiveness Analysis of the Adjunctive Therapy of Ivabradine for the Treatment of Heart Failure with Reduced Ejection Fraction
    Krittayaphong, Rungroj
    Yadee, Jirawit
    Permsuwan, Unchalee
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2019, 11 : 767 - 777
  • [6] Ivabradine for systolic heart failure
    Meade, Courtney M.
    Clements, Jennifer N.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2018, 31 (03): : 52 - 54
  • [7] Cost-Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States
    Zueger, Patrick M.
    Kumar, Varun M.
    Harrington, Rachel L.
    Rigoni, Gianna C.
    Atwood, Alicia
    DiDomenico, Robert J.
    Touchette, Daniel R.
    PHARMACOTHERAPY, 2018, 38 (05): : 520 - 530
  • [8] Cost-Effectiveness Analysis of Empagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction in the United States
    Reifsnider, Odette S.
    Tafazzoli, Ali
    Linden, Stephan
    Ishak, Jack
    Rakonczai, Pal
    Stargardter, Matthew
    Kuti, Effie
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (04):
  • [9] Cost-effectiveness analysis of carvedilol for the treatment of chronic heart failure in Japan
    Inomata, T
    Izumi, T
    Kobayashi, M
    CIRCULATION JOURNAL, 2004, 68 (01) : 35 - 40
  • [10] Ivabradine for the treatment of chronic heart failure
    Henri, Christine
    O'Meara, Eileen
    De Denus, Simon
    Elzir, Lynn
    Tardif, Jean-Claude
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2016, 14 (05) : 553 - 561
12345